Using trends in the rate of new HIV infections in east and southern Africa we assess the current state of the epidemic and evaluate the future prospects for controlling it. If we let an incidence of 1 per 1,000 people represent a control threshold then this has been reached, or will probably be reached by 2020, in East Africa and is reachable by 2020 in those southern African countries that do not have strong social and economic ties to South Africa, if they continue to scale up their treatment programmes. South Africa, Lesotho, Mozambique and Swaziland could reach the control threshold by 2030 with sufficient political will and commitment to ‘treatment for all’.
The far-reaching, highly ambitious Sustainable Development Goals (SDGs) build upon the momentum generated by the Millennium Development Goals (MDGs) and are intended as a guide for health, social and economic initiatives until 2030. Implemented correctly, the STI agenda may well fit better within the SDGs than the MDGs, although that does not become directly clear at first glance. For refocusing attention on the control of STIs in the forthcoming years we propose a framework, most especially within low- and middle-income countries (LMICs).
There have been numerous papers and books on South Africa’s catastrophic era of AIDS denialism. There is much less known and written about the “when-to-start antiretrovirals (ARVs)” debate. This debate offers a fascinating look at how scientific disagreements between reasonable people, who are experts in the field, work, and how consensus evolves as evidence accumulates.
Reflecting on Professor Mayosi’s death, it seems almost impossible not to wonder how mental health is managed in the workplace. There is growing evidence of the impact of mental health on society in general but not so much on the workforce.
Faced with more stringent regulations and plummeting sales in the developed west, the tobacco industry’s future hinges on the hope of a sales boom in emerging markets in Africa and Asia. Africa, with its fast growing youthful population and rising prosperity, is even more appealing. This article discusses some of the hidden truths of the tobacco industry.
The South African Field Epidemiology Training Programme (SAFETP) is requesting applications for the incoming 2019 class from qualified health professionals with an interest in public health and commitment to public service.
The Global Journal of Medicine and Public Health is a peer reviewed, open access journal, with an international editorial board. Integrating biomedical, social and environmental sciences, we welcome a wide range of contributions with an emphasis on development and lower income settings in order to support the evidence base for disease prevention and control.
Some interesting articles relating to the African setting that have been published in the latest issue are:
- Prevalence and risk factors of acute respiratory infection among under five sin rural communities of Ekiti State, Nigeria
By Oluremi Olayinka Solomon, Olugbenga Olusola Odu, Eyitope Oluseyi Amu, Olusoji Abidemi Solomon, James O Bamidele, Eyitayo Emmanuel, Stella Adetokunbo, Bayo D Parakoyi
- A case for strengthening pharmacovigilance systems in Namibia
By Adenuga BA, Kibuule
Many people worldwide who fall ill with Tuberculosis have no access to quality care, hence increasing efforts to close this enormous gap will be crucial in the forthcoming years to effectively reduce TB incidence and mortality worldwide.
The final results of a 4-year project to analyse the challenges and opportunities for health in sub-Saharan Africa are now published as a Lancet Commission—The Path to Longer and Healthier Lives for All Africans by 2030—led by African physicians, health scientists, and policy makers.
The year 2018 will mark the 100th anniversary of the 1918 Spanish flu pandemic. There was no digital communication then to disrupt - or aid - the outbreak response, but there were also far fewer health technologies available, while rapid spread of the virus by plane travel was very limited. In 2018, when we face the next major infectious disease outbreak, it will be a test of how well we use - or abuse - the technologies and knowledge we've gained since 1918.